Søgning på udtrykket 'pneumoni' giver 58 resultater
Dokumenter [5] Sider [2] Kalender [10] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [5]
1. udgave, forventes opdateret i løbet af 2022. Retningslinjerne er udarbejdet af en arbejdsgruppe med repræsentanter fra Dansk Lungemedicinsk Selskab og Dansk Selskab for Infektionsmedicin.
Version 8 (21.11.22) Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi & Fagligt Selskab for Hygiejnesygeplejersker
Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.
Sider [2]
…iese. Osteomyelitis: Nis Pedersen Jørgensen (tovholder), Nina Weis, Terese Katzenstein, Pernille Ravn, Lotte Ebdrup, Henrik Nielsen, Theis Aagaard og Michala Kehler Guidelines for diagnostik og behandling af spondylodiskitis, Pneumoni: Christian Philip Fischer (tovholder), Sebastian Von Huth, Lars Toft, Lone Mygind, Camilla Hatleberg, Thomas Benfield Pneumoni, Rationel antibiotikaanvendelse: Trine Langfeldt Hagen (tovholder), Shakil Shakar, Susanna Deutch, K…
…cu Johansen. 13.45-14.45. Lunge absces, empyem og Aspergillus. Formaliserede indlæg. Plenumdiskussion. Christian Laursen. 14.45-15.00. Pause. . . 15.00-16.00. Non-infektiøse pneumonier. Formaliserede indlæg. Plenumdiskussion. Jesper Davidsen. 16.00-16.15. Opsamling og evaluering. . Anbefalet læsning: TB og non-tuberkuløse mykobakterier. "Tuberkulose - diagnostik og beha…
…ndgrens studie af, hvornår man kan holde op med at give pneumocyste-profylakse til HIV-smittede eller de Gans studiet, der ændrede fik indført dexamethason i retningslinjerne for purulent meningitis. Her er formentlig et nyt studie, der kommer til at få indflydelse på standardbehandlingen af patienter med svær pneumoni. Læs en gang - og døm selv - jeg tager den med til næste års "Journal Highlights of the year", men tænkte at den måske allerede nu var god at få kendskab til. God læselyst :-)
Kalender [10]
21. marts, Fredericia
17. marts, Online og Cape Town, Sydafrika
10. maj 2023, Mærsk Tårnet, Panum Instituttet
6. maj 2022, Hindsgavl, Middelfart
16. juni 2021, Online
26. november 2018, Liverpool, England
9. november 2018, Korsør
12. oktober 2018, Nordsjællands Hospital Hillerød
9. marts 2018, Auditoriet, Nordsjællands Hospital Hillerød
2. april 2014, Cape Town, Sydafrika
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Infection
18.05.2024
. Abstract. . Purpose. Coronavirus disease 2019 (COVID-19) and non-COVID-19 community-acquired pneumonia (NC-CAP) often result in hospitalization with considerable risks of mortality, ICU treatment, and long-term morbidity. A comparative analysis of clinical outcomes in COVID-19 CAP (C-CAP) and NC-CAP may improve clinical management. . . . Methods. Using pr…
Lancet
17.05.2024
A 57-year-old woman with a 3-day history of abdominal pain, vomiting, diffuse myalgia, and a temperature peaking at 39°C presented to her local hospital. The patient had a medical history of hypertension and type 2 diabetes and was prescribed losartan and metformin.
Critical Care Medicine
16.05.2024
Objectives: . To assess the effects of antibiotics delivered via the respiratory tract in preventing ventilator-associated pneumonia (VAP). Data Sources: . We searched PubMed, Scopus, the Cochrane Library, and ClinicalTrials.gov for studies published in English up to October 25, 2023. Study Selection: . Adult patients with mechanical ventilation of over 48 h and receiving inhaled or instilled antibiotics (with control group) to prevent VAP were included. Data Extraction: . Two independent groups scree…
Clinical Infectious Diseases
16.05.2024
…es.Methods . We conducted a randomized trial in Gambia and Burkina Faso where women received intrapartum azithromycin (2g) or placebo. We determined impact of treatment on prevalence of carriage and antibiotic resistance of Escherichia coli and Klebsiella pneumoniae by analysing rectal swabs (RS), nasopharyngeal swabs (NPS), breast milk and recto-vaginal swabs (RVS). Bacteria were isolated microbiologically; antibiotic susceptibility was confirmed with an E-test. Prevalence ratios (PR) with 95% confidence i…
PLoS One Infectious Diseases
15.05.2024
by Naoki Watanabe, Tomohisa Watari, Yoshihito Otsuka, Masahiko Ito, Kazufumi Yamagata, Miyuki Fujioka . Introduction The study of Klebsiella quasipneumoniae, Klebsiella variicola, and AmpC production in extended-spectrum β-lactamase (ESBL)-producing Klebsiella in Japan is limited, and existing data are insufficient. This study aims to characterize Klebsiella species, determine AmpC production rates, and analyze antimicrobial resistance patterns in ESBL-producing Klebsiella isolates in Japan. Methods A to…
Antimicrobial Agents And Chemotherapy
15.05.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Journal of the American Medical Association
15.05.2024
About 12% of patients were inappropriately diagnosed with community-acquired pneumonia (CAP), according to results from more than 17 000 hospitalized patients across 48 hospitals in Michigan. Older people as well as those with dementia or altered mental status were at particularly high risk of being inappropriately diagnosed, which the researchers defined as patients receiving antibiotics when they had fewer than 2 symptoms of pneumonia or negative chest x-ray results.
Virulence
13.05.2024
Volume 15, Issue 1, December 2024 .
Clinical Microbiology and Infection
11.05.2024
We read with interest the comment by Zayet et al. [1] to our paper recently published into Clinical Microbiology Infection concerning the unexpected increase of severe Mycoplasma pneumoniae pneumonia in Southern Switzerland [2]. In this regard, some points of our paper should be better described.
Infection
10.05.2024
…mase-producing Enterobacterales (CPE) are not well characterized. The objective was to provide detailed information about the clinical and molecular epidemiological features of nosocomial, HCA and CA infections caused by carbapenemase-producing Klebsiella pneumoniae (CP-Kp) and Escherichia coli (CP-Ec). . . . Methods. A prospective cohort study was performed in 59 Spanish hospitals from February to March 2019, including the first 1…
Infection
10.05.2024
. Abstract. . Purpose. Patients hospitalized for community-acquired pneumonia (CAP) may have a higher risk of new-onset atrial fibrillation (NOAF). The C2HEST score was developed to evaluate the NOAF risk in the general population. Data on the value of the C2HEST score in acute patients admitted with CAP are lacking. We want to establish the predictive value of C2HEST score for NOAF in patients with CAP. . . …
International Journal of Infectious Diseases
10.05.2024
The sharp increase in mycoplasma pneumoniae (MP) infection among children in mainland China in 2023 has raised concerns about a traditional infectious disease epidemic[1]. However, it is still impossible to accurately judge the epidemic scale, the infected objectives and the clinical outcome[2]. Until the mid-2023, strong regional epidemics occurred in northern China, mycoplasma pneumoniae pneumonia (MPP) in children attracted the attention of the World Health Organization[3].
Clinical Microbiology and Infection
9.05.2024
In this study, we aimed to assess the efficacy of different ways of administration and types of beta-lactams for hospitalized community-acquired pneumonia (CAP).
Infection
8.05.2024
…mase-producing Enterobacterales (CPE) are not well characterized. The objective was to provide detailed information about the clinical and molecular epidemiological features of nosocomial, HCA and CA infections caused by carbapenemase-producing Klebsiella pneumoniae (CP-Kp) and Escherichia coli (CP-Ec). . . . Methods. A prospective cohort study was performed in 59 Spanish hospitals from February to March 2019, including the first 1…
Infection
8.05.2024
. Abstract. . Purpose. Patients hospitalized for community-acquired pneumonia (CAP) may have a higher risk of new-onset atrial fibrillation (NOAF). The C2HEST score was developed to evaluate the NOAF risk in the general population. Data on the value of the C2HEST score in acute patients admitted with CAP are lacking. We want to establish the predictive value of C2HEST score for NOAF in patients with CAP. . . …
Journal of Medical Virology
3.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
Virulence
3.05.2024
Volume 15, Issue 1, December 2024 .
American Journal of Respiratory and Critical Care Medicine
2.05.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 9, Page 1121-1131, May 1, 2024.
American Journal of Respiratory and Critical Care Medicine
2.05.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 9, Page 1170-1173, May 1, 2024.
Lancet Respiratory Medicine
1.05.2024
In a pre-specified subgroup analysis of the APROCCHSS trial of patients with CAP and septic shock, hydrocortisone plus fludrocortisone reduced mortality as compared with placebo. Although a large proportion of patients with CAP also met criteria for ARDS, the subgroup analysis was underpowered to fully discriminate between ARDS and CAP modifying effects on mortality reduction with corticosteroids. There was no evidence of a significant treatment effect of corticosteroids in the non-CAP subgroup.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Medscape Infectious Diseases
9.05.2024
Researchers examined time to clinical stability in 571 children hospitalized with community-acquired pneumonia. . Medscape Medical News
Eurosurveillance latest updates
19.04.2024
In 2023, an increase of OXA-48-producing Klebsiella pneumoniae was noticed by the Lithuanian National Public Health Surveillance Laboratory. Whole genome sequencing (WGS) of 106 OXA-48-producing K. pneumoniae isolates revealed three distinct clusters of carbapenemase-producing K. pneumoniae high-risk clones, including sequence type (ST) 45 (n = 35 isolates), ST392 (n = 32) and ST395 (n = 28), involving six, six and nine hospitals in different regions, respectively. These results enabled targeted…
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Medscape Infectious Diseases
15.02.2024
The ECDC has called for mitigating actions in the face of more European Union and European Economic Area countries reporting hypervirulent Klebsiella pneumoniae ST23. . Medscape Medical News
Medscape Infectious Diseases
26.01.2024
Exblifep is as effective as piperacillin-tazobactam in the treatment of complicated urinary tract infections, the European Medicines Agency said. . Medscape Medical News
Eurosurveillance latest updates
26.01.2024
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especial…
Eurosurveillance latest updates
12.01.2024
We report a surge of patients, especially children and adolescents, with respiratory disease caused by Mycoplasma pneumoniae in Denmark since October 2023. While the surge has reached an epidemic level, no impact on hospital capacity has been observed; only 14% (446/3,195) of cases, primarily adults, required hospitalisation. Macrolide resistance was detected in less than 2% of samples tested. Timely monitoring of hospitalisations linked to M. pneumoniae infections has been established to inform the healthc…
Eurosurveillance latest updates
24.11.2023
. Background. Preliminary unpublished results of the survey of carbapenem- and/or colistin-resistant Enterobacterales (CCRE survey) showed the expansion of carbapenemase-producing Klebsiella pneumoniae (CPKP) sequence type (ST) 39 in 12 of 15 participating Greek hospitals in 2019. . . Aim. We conducted a rapid survey to determine the extent of spread of CPKP high-risk clones in Greek hospitals in 2022 and compare the distribution of circulating CPKP clones in these hospitals since 2013. . . Methods. We …
Eurosurveillance latest updates
20.10.2023
. Background. Since 2021, an emergence of New Delhi metallo-β-lactamase (NDM)-14-producing Klebsiella pneumoniae has been identified in France. This variant with increased carbapenemase activity was not previously detected in Enterobacterales. . . Aim. We investigated the rapid dissemination of NDM-14 producers among patients in hospitals in France. . . Methods. All NDM-14-producing non-duplicate clinical isolates identified in France until June 2022 (n = 37) were analysed by whole genome sequencin…
Eurosurveillance latest updates
20.10.2023
New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae (Kp) ST147 caused a large multi-hospital outbreak in Italy from 2018 to 2021. We describe a new ST6668 NDM-producing Kp clone, belonging to CC147, which rapidly spread across hospitals in the Pavia province (Northern Italy) from February to August 2023. Genomic analyses revealed that ST6668 is different from ST147 and fast evolving. As shown here, genomic surveillance programmes are useful for tracking the spread of new clones with reduc…
Medscape Infectious Diseases
26.09.2023
New research from Northwestern University and the University of Wisconsin, however, is pointing to bacterial pneumonia as the cause of many severe COVID deaths. . WebMD Health News
Medscape Infectious Diseases
19.09.2023
Clinicians should consider all three etiologies on community-acquired pneumonia presentation to improve antimicrobial stewardship and patient outcomes. . CDC Expert Commentary
ProMED
13.05.2023
Pneumonia -- IraqFollowing a surge in meningitis cases in Halabjah City and Sulaymaniyah governorate since mid-April 2023, an expert team from the World Health Organization (WHO) and the Ministry of Health was deployed to the affected areas to perform a joint epidemiological investigation of the reported cases and develop a swift response plan to curb the transmission of the disease.Preliminary laboratory results from 24 collected samples showed a mixture of bacterial (_Streptococcus pneumoniae_) and viral
ProMED
7.05.2023
…fection -- United StatesA bacterial outbreak at Virginia Mason Medical Center in Seattle has sickened 31 patients since October [2022]. Seven of them have since died, but it's unknown what caused those deaths -- the infection or the diagnoses that brought them to the hospital in the first place._Klebsiella pneumoniae_ is a bacterium usually found in health care settings, and often resistant to antibiotics. It can cause pneumonia, meningitis, and wound or bloodstream infections.Virginia Mason is working with
ProMED
28.04.2023
Klebsiella pneumoniae -- United StatesFour patients at a downtown Seattle hospital are dead in connection to an outbreak of a bacterium often found in healthcare settings that has developed resistance to some antibiotics.The [31] infected patients, who contracted _Klebsiella_, were hospitalized in various departments, including inpatient medical beds, an ICU, and an operating room at Virginia Mason Medical Center, the hospital said in a statement released Wednesday [26 Apr 2023].Beginning in October 2022, h…
Eurosurveillance latest updates
28.04.2023
A hypervirulent Klebsiella pneumoniae SL218 (ST23-KL57), phylogenetically distinct from the classical hypervirulent SL23 (ST23-KL1) lineage, was transmitted between hospitalised patients in Denmark in 2021. The isolate carried a hybrid resistance and virulence plasmid containing blaNDM-1 and a plasmid containing blaOXA-48 (pOXA-48); the latter plasmid was horizontally transferred within-patient to Serratia marcescens. The convergence of drug resistance and virulence factors in single plasmids and in differe…
Eurosurveillance latest updates
15.12.2022
In 2022, German surveillance systems observed rapidly increasing numbers of NDM-1- and NDM-1/OXA-48-producing Klebsiella pneumoniae, which may in part reflect recurring pre-pandemic trends. Among these cases, however, a presence in Ukraine before diagnosis was frequently reported. Whole genome sequencing of 200 isolates showed a high prevalence of sequence types ST147, ST307, ST395 and ST23, including clusters corresponding to clonal dissemination and suggesting onward transmission in Germany. Screening and…
Eurosurveillance latest updates
10.11.2022
…allow identification of novel bacterial species. This can affect surveillance of infections and antimicrobial resistance. From 2017, increasing numbers of medical microbiology laboratories in Switzerland differentiated Klebsiella variicola from Klebsiella pneumoniae complex using updated MALDI-TOF databases, whereas many laboratories still report them as K. pneumoniae or K. pneumoniae complex. Aim. Our study explored whether separate reporting of K. variicola and the Klebsiella pneumoniae complex affected t…
ProMED
31.10.2022
Hospital-Related Infection -- Jamaica
Eurosurveillance latest updates
27.10.2022
A nosocomial outbreak by cefiderocol (FDC)-resistant NDM-1-producing Klebsiella pneumoniae (NDM-Kp) occurred in a large tertiary care hospital from August 2021–June 2022 in Florence, Italy, an area where NDM-Kp strains have become endemic. Retrospective analysis of NDM-Kp from cases observed in January 2021–June 2022 revealed that 21/52 were FDC-resistant. The outbreak was mostly sustained by clonal expansion of a mutant with inactivated cirA siderophore receptor gene, which exhibited high-level…